Skip to main content

14 Result(s)

within R. Cozzi Remove this filter Medicine/Public Health, general Remove this filter

and

  1. Article

    Open Access

    Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up

    Pasireotide LAR (PAS-LAR) was released in Italy in 2017 to treat acromegaly patients resistant to SRLs (Somatostatin Receptors Ligands). The long-term follow-up data of PAS-LAR therapy in Italy are limited. Th...

    C. Urbani, F. Dassie, B. Zampetti, R. Mioni… in Journal of Endocrinological Investigation (2024)

    Download PDF (789 KB) View Article

  2. No Access

    Article

    Screening della sindrome di Cushing in pazienti ambulatoriali con diabete mellito di tipo 2: risultati di uno studio prospettico multicentrico in Italia

    M. Terzolo, G. Reimondo, I. Chiodini, R. Castello, R. Giordano… in L’Endocrinologo (2012)

  3. No Access

    Article

    Perioperative Cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas

    Background: Peri-operative steroids are administered routinely to patients with pituitary adenoma undergoing transsphenoidal adenomectomy (TSA). Aim: To evaluate hypothalamic-pituitary-ad...

    R. Cozzi, G. Lasio, A. Cardia, G. Felisati… in Journal of Endocrinological Investigation (2009)

  4. No Access

    Article

    Efficacy of the new long-acting formulation of lanreotide (Lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly

    Objective: To evaluate efficacy and safety of lanreotide autogel (ATG) 120 mg injections every 4–8 weeks in somatostatin analogue-na"ive patients with acromegaly. Design: Open, non-compar...

    G. Lombardi MD, PhD, F. Minuto, G. Tamburrano… in Journal of Endocrinological Investigation (2009)

  5. No Access

    Article

    Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients

    Context: Development of gallstones (GS) is reported during the use of somatostatin analogs (SA) that are at present the mainstay for the medical treatment of acromegaly. Objective: To rev...

    R. Attanasio MD, A. Mainolfi, F. Grimaldi… in Journal of Endocrinological Investigation (2008)

  6. No Access

    Article

    Pegvisomant in acromegaly: Why, when, how

    A. Colao, G. Arnaldi, P. Beck-Peccoz… in Journal of Endocrinological Investigation (2007)

  7. No Access

    Article

    First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group

    A. Colao MD, E. Martino, P. Cappabianca… in Journal of Endocrinological Investigation (2006)

  8. No Access

    Article

    La risposta agli analoghi della somatostatina migliora dopo resezione parziale del tumore ipofisario GH-secernente nei pazienti con acromegalia

    L’intervento chirurgico di adenomectomia rappresenta uno dei capisaldi del trattamento dell’acromegalia; peraltro, la sua efficacia nei tumori ipofisari GH-secernenti di grosse dimensioni e con spiccate caratt...

    A. Colao, R. Attanasio, R. Pivonello, P. Cappabianca, L. M. Cavallo… in L’Endocrinologo (2006)

  9. No Access

    Article

    Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

    Three cases of cerebrospinal fluid (CSF) leak, in subjects with an invasive macroprolactinoma under treatment with cabergoline (CAB), are reported. The patients underwent surgical treatment by means of an endo...

    Dr. P. Cappabianca, S. Lodrini, G. Felisati… in Journal of Endocrinological Investigation (2001)

  10. No Access

    Article

    Scintigraphic imaging of pituitary adenomas: An in vivo evaluation of somatostatin receptors

    We have performed pituitary scintigraphy with the somatostatin (SS) analog pentetreotidean by (111In-P) in patients with GH-secreting adenoma or with “clinically non functioning” adenoma (NFA) to evaluate the pre...

    Dott. G. Oppizzi, R. Cozzi, D. Dallabonzana… in Journal of Endocrinological Investigation (1998)

  11. No Access

    Article

    Doxorubicine for acromegaly: a case report

    We report the case of an acromegalic woman, aged 35 years, with a huge GH-secreting tumor, repeatedly treated with neurosurgery and radiotherapy, not responsive to bromocriptine (Br) and octreotide (SMS), whos...

    dr. Roberto Attanasio, P. Orlandi… in Journal of Endocrinological Investigation (1991)

  12. No Access

    Article

    Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis

    In six patients suffering from amyotrophic lateral sclerosis we evaluated changes of T4, T3, TSH, PRL, and GH during treatment by continuous iv infusion of TRH for at least 15 days. No clinical improvement was...

    Dr. Pier G. Chiodini, R. Attanasio, A. Liuzzi… in Journal of Endocrinological Investigation (1990)

  13. No Access

    Article

    Resistance to a long-acting somatostatin analog (SMS 201-995) reversed by surgery in acromegaly

    A 42-year-old woman had acromegaly and a large macroadenoma with supra- and parasellar extension. Her GH levels (median 85 ng/ml, range 63–170 ng/ml) were not responsive to TRH (200 μg iv), GHRH (100 μg iv) an...

    Roberto Attanasio, P. G. Chiodini, A. Liuzzi… in Journal of Endocrinological Investigation (1990)

  14. No Access

    Article

    Effectiveness.of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states

    We have studied the effects of the chronic administration of the dopamine agonist lisuride (L) in 21 acromegalics (group 1) and in 25 patients with pathological hyperprolactinemia (group 2). Before starting th...

    G. Verde, P. G. Chiodini, Dr. A. Liuzzi… in Journal of Endocrinological Investigation (1980)